Astellas Pharma
Retina Matters
Welcome to “Retina Matters," where eye care professionals come together to share their insights, experiences, and discuss the latest in treatment for retinal diseases – tune in and stay ahead of the curve. Please see episode description for Important Safety Information and visit bit.ly/4l9n7oP for full Prescribing Information. For U.S. Healthcare Professionals Only. MAT-US-IZE-2025-00225 06/25
Autor
Astellas Pharma
Categoría
Web del podcast
Último episodio
29 de jun. de 2026
¿Dónde escuchar?
Podcasts en la app Replaio Radio Muy prontoLos podcasts llegarán muy pronto a la app. Instálala ahora y sé el primero en descubrir una forma totalmente nueva de vivir los podcasts
Instálala gratis
Android casi 10 M de descargas · valoración de 4,8
iOS muy pronto
Episodios
Rethinking GA: A Clinical Shift Toward Earlier Detection and Management Video 29.06.2026 17:49
Geographic atrophy (GA) management is rapidly evolving. In this episode, host Weslie Hamada, OD, FAAO, sits down with retina specialist David Chin Yee, MD, to discuss how therapies are changing the way clinicians identify and approach GA. From imaging-based risk assessment to referral coordination and treatment considerations, they examine opportunities for proactive management to help slow the pr...
From Trial to Treatment: Bridging the Gap with OLE Data in GA Management Video 04.06.2026 19:49
In this episode of Retina Matters, host Weslie Hamada, OD, FAAO, sits down with renowned retina specialist Arshad Khanani, MD, to take a closer look at what the open label extension (OLE) trial tells us about the treatment of geographic atrophy (GA). From added clinical nuance to real-world decision-making, they unpack how emerging insights are shaping a more informed, forward-looking approach to...
Podcasts similares
Escucha el podcast Retina Matters en Replaio
Radio y podcasts en una sola app - gratis y sin registro. Instálala hoy y no te pierdas el estreno
Replaio no es editor de podcasts; los nombres de los programas, las portadas y el audio pertenecen a sus autores y se distribuyen a través de canales RSS públicos
